Avista Healthcare

09/03/2025 – 08:00 AM New investment to fuel growth trajectory and development of award-winning, next-gen XiFin® Empower platform Funding led by a co-investment from Goldman Sachs, alongside majority investor Avista Healthcare Partners and other leading institutional investors SAN DIEGO–(BUSINESS WIRE)– XiFin, a leader in revenue cycle management (RCM) and billing solutions enhanced with embedded artificial intelligence […]

NEW YORK, Sept. 2, 2025 – Avista Healthcare Partners (Avista), a private equity firm focused exclusively on healthcare, today announced an agreement to participate in PK Benelux, a key player in the market for vitamins, minerals, and supplements (VMS) in the Netherlands. Founded in 1985 and headquartered in Uden, the Netherlands, PK Benelux is owned by its founders Albert Peters and Angela […]

New York, June 4, 2025 – Avista Healthcare Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced its acquisition of EBI, the bone healing division of Highridge Medical (“EBI” or the “Company”). The acquisition marks the 50th platform healthcare investment for Avista and its founding members – underscoring the firm’s long-standing […]

TAMPA, FL. April 1, 2025– Probo Medical (“Probo”), a global diagnostic imaging solutions provider, has announced its new distribution relationship with GE HealthCare. This relationship signifies a major milestone for Probo and reinforces its dedication to offering our customers advanced medical imaging technology in the industry. In this relationship, Probo will offer new GE HealthCare […]

UNION CITY, Calif., Jan. 7, 2025 /PRNewswire/ — GCM, a leading outsourced manufacturer of precision components and assemblies focused on the medical technology end markets, today announced the asset acquisition of Precision Swiss Products (“PSP”), a leading provider of technical machining solutions. GCM is a portfolio company of Avista Healthcare Partners, a leading middle-market healthcare […]

Net proceeds to fund the Company’s strategic growth initiatives, enhance balance sheet flexibility, and finance privately negotiated stock repurchases CANTON, Mass. (November 12, 2024) – Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine […]

Combination strengthens eMolecules’ position as the global one-stop-shop solution provider for efficient chemical compound procurement, full-service compound management and automation solutions for drug discovery researchers SAN DIEGO and ZURICH, Sept. 24, 2024 /PRNewswire/ — eMolecules, Inc., provider of the industry-leading chemical compound search-and-fulfillment platform for early discovery chemistry research, today announced that it has acquired […]

TAMPA, FL. September 13, 2024– Probo Medical (“Probo”), a global diagnostic imaging solutions provider, has announced the appointment of Michael Asmer as Chairman of the Board and Greg Kopulos as Chief Executive Officer of Probo. Michael Asmer was formerly Chief Executive Officer of Probo and, prior to Probo, was the founder and Chief Executive Officer […]

Addition of vH essentials® bolsters scale, portfolio diversity, and provides opportunities to accelerate WellSpring’s fast-growing Women’s Health segment SARASOTA, Fla., Aug. 1, 2024 /PRNewswire/ — WellSpring Consumer Healthcare (“WellSpring”), a developer and marketer of leading over-the-counter (“OTC”) and personal care brands, today announced the acquisition of vH essentials® from Wisconsin Pharmacal Company. Financial terms of […]

Significantly Enhances Cosette’s Ability to Drive Further Growth Through Investments in Business Development and R&D Bridgewater, NJ, Conshohocken, PA, and New York, NY – July 17, 2024 – Avista Capital Partners (“Avista”), a leading New York-based private equity firm focused exclusively on healthcare, and Hamilton Lane, a leading global private markets investment management firm (Nasdaq: […]

Seamless Transition Ensures Continued Supply for Patients Who Depend on Ambien® Acquisition Builds on Cosette’s Leading Expertise in Carving Out Critical Drugs from Global Pharma Companies BRIDGEWATER, N.J.–(BUSINESS WIRE)–Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical company, has completed the acquisition of Ambien® and Ambien CR® in the United States from Sanofi US. “We are […]

Paris, France – Cooper Consumer Health is delighted to announce the successful completion of the acquisition of ’Over the Counter (OTC)’ business of Viatris Inc., a global healthcare company. This milestone follows the necessary approvals from regulatory authorities and the completion of workers’ councils’ information and consultation processes. The acquisition doubles Cooper Consumer Health’s revenues […]